<p>The levels of p14<sup>ARF</sup> and p16<sup>INK4a</sup> in Sal BL were analyzed at 4 days post-transfection and not detected. Sal cells were transfected in duplicate with expression vectors for either EBNA-3A-specific shRNA 1490 or 601, control shRNA (C2) or empty vector (oriP). Saos2 and MCF7 serve as positive controls for detection of p14<sup>ARF</sup> and p16<sup>INK4a</sup>; GAPDH, loading control. Knockdown of EBNA-3A was similar to that shown in <a href="http://www.plospathogens.org/article/info:doi/10.1371/journal.ppat.1004415#ppat-1004415-g002" target="_blank">Figure 2A</a>.</p
<p>A-C) 10 million EBV-negative BJAB, Ramos, EBNA3C stable expressing BJAB7, BJAB10, EBV-transformed...
<p>Immunoblots of transfected Sal cells harvested at (A) 4 days or (B) 8 days post-transfection were...
<p>A–B) 10 million HEK-293 cells were transiently transfected with different combinations of express...
<p>Cell lysates from Sal BL cells transfected with the empty shRNA expression vector (oriP-GFP) or v...
<p>A, B, C, D) 10 million HEK-293 cells were transiently transfected with different combinations of ...
(A) 10 million Saos-2 cells were transfected with control vector, plasmids encoding EBNA3C, RASSF1A....
The two products of the Ink4a-Arf locus, p16(Ink4a) and p19(Arf) (p14(ARF) in humans), are potent tu...
<p>A–B) Approximately10 million human peripheral blood mononuclear cells (PBMC) were infected by eit...
<p>A) 10×10<sup>6</sup> human PBMC (Peripheral blood mononuclear cells) were infected with BAC-GFP E...
<p>(A) Transcomplementation assay comparing growth of EBNA3A-HT cells transfected with EBNA3A WT (cl...
<p>(A) Cell cycle profiles of GFP-positive Sal cells 3 days post-transfection with oriP-GFP empty ve...
<p>A–B) 50 million EBV negative DG75 cells were transfected with increasing amount of A) IRF4 and B)...
<div><p>To explore the role of p16<sup>INK4a</sup> as an intrinsic barrier to B cell transformation ...
<p>A-F) 10 million HEK-293 or Saos-2 cells were transfected with pGL2 control vector, full-length E2...
<p><b>(A)</b> Western blots of LCL cells transduced with either control shRNA (shCtrl) or shEBF1 (le...
<p>A-C) 10 million EBV-negative BJAB, Ramos, EBNA3C stable expressing BJAB7, BJAB10, EBV-transformed...
<p>Immunoblots of transfected Sal cells harvested at (A) 4 days or (B) 8 days post-transfection were...
<p>A–B) 10 million HEK-293 cells were transiently transfected with different combinations of express...
<p>Cell lysates from Sal BL cells transfected with the empty shRNA expression vector (oriP-GFP) or v...
<p>A, B, C, D) 10 million HEK-293 cells were transiently transfected with different combinations of ...
(A) 10 million Saos-2 cells were transfected with control vector, plasmids encoding EBNA3C, RASSF1A....
The two products of the Ink4a-Arf locus, p16(Ink4a) and p19(Arf) (p14(ARF) in humans), are potent tu...
<p>A–B) Approximately10 million human peripheral blood mononuclear cells (PBMC) were infected by eit...
<p>A) 10×10<sup>6</sup> human PBMC (Peripheral blood mononuclear cells) were infected with BAC-GFP E...
<p>(A) Transcomplementation assay comparing growth of EBNA3A-HT cells transfected with EBNA3A WT (cl...
<p>(A) Cell cycle profiles of GFP-positive Sal cells 3 days post-transfection with oriP-GFP empty ve...
<p>A–B) 50 million EBV negative DG75 cells were transfected with increasing amount of A) IRF4 and B)...
<div><p>To explore the role of p16<sup>INK4a</sup> as an intrinsic barrier to B cell transformation ...
<p>A-F) 10 million HEK-293 or Saos-2 cells were transfected with pGL2 control vector, full-length E2...
<p><b>(A)</b> Western blots of LCL cells transduced with either control shRNA (shCtrl) or shEBF1 (le...
<p>A-C) 10 million EBV-negative BJAB, Ramos, EBNA3C stable expressing BJAB7, BJAB10, EBV-transformed...
<p>Immunoblots of transfected Sal cells harvested at (A) 4 days or (B) 8 days post-transfection were...
<p>A–B) 10 million HEK-293 cells were transiently transfected with different combinations of express...